Loading...
Loading...
By Juan Luis Serrano Leets - Mon, 01/23/2023 - 12:00
Juan Luis Serrano analyzes the new rules related to health supplies and their possible consequences in providing patients with access to innovation.
https://mexicobusiness.news/tag/sanchez-devanny
More Health
By Juan Luis Serrano Leets - Thu, 10/06/2022 - 12:00
COFEPRIS is facing a severe backlog. Juan Serrano looks at three actions that can be taken by the authorities and industry to address the problem.
By Miriam Bello - Mon, 09/05/2022 - 12:24
Advances and ongoing challenges have paved the way for the transformation of Mexico’s health system.
By Sofía Garduño - Wed, 08/31/2022 - 16:32
Healthcare providers are embracing pharmacoeconomics to make better decisions, but the field must also improve.
By Miriam Bello - Wed, 08/10/2022 - 08:28
The Digital Health Law and other regulations need clarity to support the provision of health services, says Sanchez Devanny's Juan Luis Serrano.
By Juan Luis Serrano Leets - Mon, 07/25/2022 - 09:00
Patent owners in Mexico are benefiting from a Supreme Court decision related to prosecution delays and compensation, writes Juan Luis Serrano.
By Juan Luis Serrano Leets - Wed, 04/20/2022 - 11:00
Court decision against COFEPRIS is a first step that could pave the way for more drugs and devices coming to Mexico, writes Juan Luis Serrano.
By Alfonso Núñez - Wed, 02/16/2022 - 15:09
Industry experts discuss the need for regulation as well as best practices and benefits during the Digital Health Regulation panel of MHS 2022.
By Mónica López - Tue, 02/16/2021 - 09:40
The pharmaceutical industry is going through intensive therapy, not as a patient but as an ally in supporting the health sector and its users
By Andrea Villar - Wed, 01/27/2021 - 12:30
The pharmaceutical industry is going through intensive therapy, not as a patient but as an ally in supporting the health sector and its users